Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
Send Cancel

VMD assures market access to medicines after Brexit
The VMD has confirmed that marketing authorisation holders can continue to be based in the UK and access EU markets.
Document sets out implementation plans for life sciences

Market access to medicines during the Brexit implementation period will not change for the life science sector, the Veterinary Medicines Directorate (VMD) has confirmed.

In a document titled ‘Technical information on what the implementation period means for the life science sector’, the VMD said that marketing authorisation holders can continue to be based in the UK and access EU markets.

‘Manufacturing and distribution licences will continue to be recognised by the EU and vice versa, as will inspections,’ it continued. ‘UK based firms can continue to apply for marketing authorisations via either the centralised or decentralised procedure.’

The VMD adds that a licence for a Centrally Authorised Product (CAP) will be valid for the EU and the UK during the implementation period (29 March 2019 - 31 December 2020).

Products that have not finished a centrally authorised assessment process at the end of the implementation period may have to start again. However, this will depend upon the outcome of negotiations on the UK’s future relationship with the EU.

The assurance comes after concerns were raised by the European Medicines Agency (EMA) about how prepared marketing authorisation holders were for Brexit. A survey by the agency found that just 58 per cent of market authorisation holders for CAPs are on track with their planning for the UK’s exit from the EU.


Become a member or log in to add this story to your CPD history

Nominations for 2019 RSPCA Honours Awards now open

News Story 1
 People across the UK are being urged to nominate a standout animal champion for the 2019 RSPCA Honours Awards.

The awards recognise those who have worked tirelessly to improve animal welfare, campaigned on behalf of animals, or shown true bravery. Previous winners include comedian John Bishop, who was awarded Celebrity Animal Champion of the Year, and 11-year-old Lobby Cantwell, who raised more than £1,000 for the charity through mountain climbs and bike rides.

To submit a nomination or find out more about the awards visit the RSPCA website. Nominations will remain open until 4 pm on Friday, March 15.  

Click here for more...
News Shorts
New £1m project to investigate dairy cow lameness

Scotland’s Rural College (SRUC) is leading a new £1 million research project to investigate the causes of lameness in dairy cows.

One in three dairy cows are affected by lameness every day in the UK, costing the industry an estimated £250 milion annually.

The project will take three years to complete and is due to finish by November 2021.

Professor Georgios Banos of SRUC commented: “In addition to pain and discomfort to the animal, lameness is associated with decreased milk production and inflated farm costs.

“Among cows raised in the same environment, some become lame while others do not. Understanding the reasons behind this will help us develop targeted preventive practices contributing to enhanced animal welfare and farm profitability.”